HOME › DRUGS › BECAPLERMIN
ACTIVE SUBSTANCE / INN

BECAPLERMIN

Brand name(s): Gemesis, REGRANEX, Regranex
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
REFUSED
BLA103691
Wound Healing;Skin Ulcer
ACTIVE SUBSTANCE
Becaplermin
REGULATORS
FDA · EMA
SPONSORS / MAH
SMITH AND NEPHEW, Janssen-Cilag International NV, BioMimetic Therapeutics Ltd
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
REGRANEXBLA103691SMITH AND NEPHEWPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RegranexJanssen-Cilag International NVWithdrawn29/03/1999Wound Healing;Skin Ulcer
GemesisBioMimetic Therapeutics LtdRefusedGuided Tissue Regeneration, Periodontal

FULL INTELLIGENCE ON BECAPLERMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →